FibroGen Inc - Strategy, SWOT and Corporate Finance Report

FibroGen Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

FibroGen Inc (FibroGen) is a biopharmaceutical company that discovers, and develops medicines for the treatment of anemia, cancer, and fibrotic disease. The company is investigating its lead pipeline candidate: roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor (HIF) prolyl hydroxylases (HIF-PH), for the treatment of anemia related to chronic kidney disease (CKD) in dialysis-dependent (DD) patients; and in Phase II/III clinical trials for anemia associated with myelodysplastic syndromes. Its pipeline also comprises a biosynthetic corneal implant; and pamrevlumab, a human monoclonal antibody inhibitor of connective tissue growth factor (CTGF), in Phase III clinical studies for the treatment of idiopathic pulmonary fibrosis and pancreatic cancer; and in Phase II clinical studies for the treatment of duchenne muscular dystrophy. FibroGen is headquartered in San Francisco, California, the US.

Scope

  • Detailed information on FibroGen Inc required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting FibroGen Inc in the form of a SWOT analysis
  • An in-depth view of the business model of FibroGen Inc including a breakdown and examination of key business segments
  • News about FibroGen Inc, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of FibroGen Inc and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess FibroGen Inc as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on FibroGen Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Vifor Pharma Ltd

Sandoz Inc

Pfizer Inc

Kyowa Hakko Kirin Co Ltd

Johnson & Johnson

Japan Tobacco Inc

GlaxoSmithKline Plc

F. Hoffmann-La Roche Ltd

Celgene ...

Vifor Pharma Ltd

Sandoz Inc

Pfizer Inc

Kyowa Hakko Kirin Co Ltd

Johnson & Johnson

Japan Tobacco Inc

GlaxoSmithKline Plc

F. Hoffmann-La Roche Ltd

Celgene Corp

Boehringer Ingelheim International GmbH

Bayer AG

Amgen Inc

Akebia Therapeutics Inc

Acceleron Pharma Inc

3SBio Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

FibroGen Inc - Key Facts

FibroGen Inc ...

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

FibroGen Inc - Key Facts

FibroGen Inc - Key Employees

FibroGen Inc - Key Employee Biographies

FibroGen Inc - Major Products and Services

FibroGen Inc - History

FibroGen Inc - Company Statement

FibroGen Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

FibroGen Inc - Business Description

Business Segment: Development and Other Revenue

Overview

Performance

Business Segment: License Revenue

Overview

Performance

Business Segment: Product Revenue

Overview

Performance

Geographical Segment: All other

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Japan

Performance

R&D Overview

FibroGen Inc - Corporate Strategy

FibroGen Inc - SWOT Analysis

SWOT Analysis - Overview

FibroGen Inc - Strengths

FibroGen Inc - Weaknesses

FibroGen Inc - Opportunities

FibroGen Inc - Threats

FibroGen Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

FibroGen Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

Jun 05, 2019: FibroGen appoints Suzanne Blaug to Board of Directors

May 09, 2019: FibroGen reports first quarter 2019 financial results

Feb 27, 2019: Fibrogen reports fourth quarter and full year 2018 financial results

Dec 06, 2018: FibroGen names Maykin Ho, Ph.D., as board director

Nov 08, 2018: FibroGen reports third quarter 2018 financial results

Aug 07, 2018: FibroGen reports second quarter 2018 financial results

May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results

Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results

Section 6 – Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

FibroGen Inc, Key Facts

FibroGen Inc, Key Employees

FibroGen Inc, Key Employee Biographies

FibroGen Inc, Major Products and Services

FibroGen Inc, History ...

List of Tables

FibroGen Inc, Key Facts

FibroGen Inc, Key Employees

FibroGen Inc, Key Employee Biographies

FibroGen Inc, Major Products and Services

FibroGen Inc, History

FibroGen Inc, Subsidiaries

FibroGen Inc, Key Competitors

FibroGen Inc, Ratios based on current share price

FibroGen Inc, Annual Ratios

FibroGen Inc, Annual Ratios (Cont...1)

FibroGen Inc, Interim Ratios

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

FibroGen Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

FibroGen Inc, Performance Chart (2014 - 2018)

FibroGen Inc, Ratio Charts

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD ...

List of Figures

FibroGen Inc, Performance Chart (2014 - 2018)

FibroGen Inc, Ratio Charts

FibroGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

FibroGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports